2. Search Result
Search Result
Results for "

Naltrexone

" in MedChemExpress (MCE) Product Catalog:

9

Inhibitors & Agonists

1

Peptides

3

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-76711
    Naltrexone

    		Opioid Receptor Cancer
    Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system .
    Naltrexone
  • HY-76711R
    Naltrexone (Standard)

    		Opioid Receptor Cancer
    Naltrexone (Standard) is the analytical standard of Naltrexone. This product is intended for research and analytical applications. Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system .
    Naltrexone (Standard)
  • HY-76711S
    Naltrexone-d4

    		Opioid Receptor Neurological Disease
    Naltrexone-d4 is deuterium labeled Naltrexone.
    Naltrexone-d4
  • HY-W739948
    Naltrexone-d3

    		Isotope-Labeled Compounds Others
    Naltrexone-d3 is a deuterated labeled Naltrexone (HY-76711) . Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system .
    Naltrexone-d3
  • HY-N2304
    3-O-Methyl-6β-naltrexone

    		Drug Metabolite Neurological Disease
    3-O-Methyl-6β-naltrexone is a metabolite of Naltrexone .
    3-O-Methyl-6β-naltrexone
  • HY-P2579
    Dafphedyn

    		Opioid Receptor Neurological Disease Metabolic Disease
    Dafphedyn is an analogue of Dynorphin (1-13). Dafphedyn has diuretic and profound analgesia effects that can be antagonized by centrally administered Naltrexone (HY-76711) or Naloxone (HY-17417A) .
    Dafphedyn
  • HY-108229
    6β-Naltrexol

    6β-HydroxyNaltrexone

    		 Drug Metabolite Opioid Receptor Neurological Disease
    6β-Naltrexol (6β-Hydroxynaltrexone), the primary metabolite of Naltrexone, is a peripherally selective opioid antagonist. 6β-Naltrexol selectively inhibits gastrointestinal opioid effects in human subjects and inhibits Morphine-induced slowing of gastrointestinal transit .
    6β-Naltrexol
  • HY-108229S
    6β-Naltrexol-d3

    6β-HydroxyNaltrexone-d3

    		 Isotope-Labeled Compounds Opioid Receptor Drug Metabolite Neurological Disease
    6β-Naltrexol-d3 (6β-Hydroxynaltrexone-d3) is deuterium labeled 6β-Naltrexol. 6β-Naltrexol (6β-Hydroxynaltrexone), the primary metabolite of Naltrexone, is a peripherally selective opioid antagonist. 6β-Naltrexol selectively inhibits gastrointestinal opioid effects in human subjects and inhibits Morphine-induced slowing of gastrointestinal transit .
    6β-Naltrexol-d3
  • HY-159924
    DBPR116

    		Opioid Receptor Neurological Disease
    DBPR116 is a prodrug of BPRMU191 (HY-159923) with blood-brain barrier penetration capability. DBPR116 significantly improves the delivery of centrally targeted drugs. In combination with the antagonist Naltrexone (HY-76711), DBPR116 demonstrated superior safety and analgesic efficacy compared to morphine in various in vivo pharmacological studies, including thermal pain models, cancer pain models, constipation, sedation, psychological dependence, heart rate, and respiratory frequency. As a prodrug strategy for peripheral administration, DBPR116 effectively alleviates pain while reducing adverse effects, showing potential as a safer opioid analgesic .
    DBPR116

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: